Cargando…
Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
Oncogene addiction is a cellular property by which cancer cells become highly dependent on the expression of oncogenes for their survival. Oncogene addiction can be exploited to design molecularly targeted drugs that kill only cancer cells by inhibiting the specific oncogenes. Genes and cell lines e...
Autores principales: | Ito, Reina E., Oneyama, Chitose, Aoki, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016361/ https://www.ncbi.nlm.nih.gov/pubmed/33793658 http://dx.doi.org/10.1371/journal.pone.0249388 |
Ejemplares similares
-
Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation
por: Virzì, Anna Rita, et al.
Publicado: (2018) -
MEK/ERK‐mediated oncogenic signals promote secretion of extracellular vesicles by controlling lysosome function
por: Hikita, Tomoya, et al.
Publicado: (2022) -
Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021) -
Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014) -
Targeting of non-oncogene addiction
por: Igea, Ana, et al.
Publicado: (2015)